Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial

被引：0

作者：

Abdoul Habib Beavogui

Alioune Camara

Alexandre Delamou

Mamadou Saliou Diallo

Abdoulaye Doumbouya

Karifa Kourouma

Patrice Bouedouno

Timothée Guilavogui

Samaly dos Santos Souza

Julia Kelley

Eldin Talundzic

Aissata Fofana

Mateusz M. Plucinski

机构：

[1] Centre National de Formation et de Recherche en Santé Rurale de Maferinyah,Department of Medical Sciences

[2] Gamal Abdel Nasser University,Centre d’Excellence Africain pour la Prévention et le Contrôle des Maladies Transmissibles (CEA

[3] Gamal Abdel Nasser University,PCMT)

[4] Gamal Abdel Nasser University,Department of Public Health

[5] National Malaria Control Programme,Malaria Branch

[6] Direction of Epidemiology,Atlanta Research and Education Foundation and Malaria Branch

[7] Ministry of Health,Malaria Branch and U.S. President’s Malaria Initiative

[8] Centers for Disease Control and Prevention,undefined

[9] Centers for Disease Control and Prevention,undefined

[10] RTI International,undefined

[11] Centers for Disease Control and Prevention,undefined

来源：

Malaria Journal | / 19卷

关键词：

Efficacy; Artesunate–amodiaquine; Artemether–lumefantrine; Molecular makers; Guinea;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial
Roucher, Clementine
Brosius, Isabel
Mbow, Moustapha
Faye, Babacar Thiendella
De Hondt, Annelies
Smekens, Bart
Arango, Diana
Burm, Christophe
Tsoumanis, Achilleas
Paredis, Linda
van Herrewege, Yven
Potters, Idzi
Cisse, Badara
Mboup, Souleymane
Polman, Katja
Bottieau, Emmanuel
BMJ OPEN, 2021, 11 (06):
[22] Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial
Paul Sondo
Karim Derra
Seydou Diallo-Nakanabo
Zekiba Tarnagda
Odile Zampa
Adama Kazienga
Innocent Valea
Hermann Sorgho
Ellis Owusu-Dabo
Jean-Bosco Ouedraogo
Tinga Robert Guiguemde
Halidou Tinto
Malaria Journal, 14
[23] Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial
Soukhathammavong, P.
Odermatt, P.
Sayasone, S.
Vonghachack, Y.
Vounatsou, P.
Akkhavong, K.
Hatz, C.
Keiser, J.
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 173 - 174
[24] Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial
Soukhathammavong, Phonepasong
Odermatt, Peter
Sayasone, Somphou
Vonghachack, Youthanavanh
Vounatsou, Penelope
Hatz, Christoph
Akkhavong, Kongsap
Keiser, Jennifer
LANCET INFECTIOUS DISEASES, 2011, 11 (02): : 110 - 118
[25] Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial
Kamata, Yohei
Kessoku, Takaomi
Shimizu, Tomoko
Kobayashi, Takashi
Kurihashi, Takeo
Sato, Satsuki
Kuraji, Syotaro
Aoyama, Norio
Iwasaki, Tomoyuki
Takashiba, Shogo
Hamada, Nobushiro
Kodama, Toshiro
Tamura, Toshiyuki
Ino, Satoshi
Higurashi, Takuma
Taguri, Masataka
Yamanaka, Takeharu
Yoneda, Masato
Usuda, Haruki
Wada, Koichiro
Nakajima, Atsushi
Minabe, Masato
TRIALS, 2020, 21 (01)
[26] Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial
Jean-Louis A Ndiaye
Babacar Faye
Ali Gueye
Roger Tine
Daouda Ndiaye
Corinne Tchania
Ibrahima Ndiaye
Aichatou Barry
Badara Cissé
Valérie Lameyre
Oumar Gaye
Malaria Journal, 10
[27] Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial
Yohei Kamata
Takaomi Kessoku
Tomoko Shimizu
Takashi Kobayashi
Takeo Kurihashi
Satsuki Sato
Syotaro Kuraji
Norio Aoyama
Tomoyuki Iwasaki
Shogo Takashiba
Nobushiro Hamada
Toshiro Kodama
Toshiyuki Tamura
Satoshi Ino
Takuma Higurashi
Masataka Taguri
Takeharu Yamanaka
Masato Yoneda
Haruki Usuda
Koichiro Wada
Atsushi Nakajima
Masato Minabe
Trials, 21
[28] Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial
Ndiaye, Jean-Louis A.
Faye, Babacar
Gueye, Ali
Tine, Roger
Ndiaye, Daouda
Tchania, Corinne
Ndiaye, Ibrahima
Barry, Aichatou
Cisse, Badara
Lameyre, Valerie
Gaye, Oumar
MALARIA JOURNAL, 2011, 10
[29] Therapeutic efficacy of artemether-lumefantrine in North-Eastern states of India and prevalence of drug resistance-associated molecular markers
Dutta, Shreelekha
Krishna, Sri
Vishwakarma, Anup Kumar
Mishra, Sweta
Khandai, Sushrikanta
Goswami, Disphikha
Kumari, Soni
Ali, Nazia
Verma, Anil Kumar
Singh, Kuldeep
Das, Aparup
Anvikar, Anup R.
Bharti, Praveen Kumar
MALARIA JOURNAL, 2025, 24 (01)
[30] Improving gut health and growth in early life: a protocol for an individually randomised, two-arm, open-label, controlled trial of a synbiotic in infants in Kaffrine District, Senegal
Momo Kadia, Benjamin
Khouma, Marietou
Sow, Doudou
Faye, Babacar
Ramsteijn, Anouschka S.
Calvo-Urbano, Beatriz
Jobarteh, Modou L.
Ferguson, Elaine
Haggarty, Paul
Webster, Joanne P.
Walker, Alan W.
Heffernan, Claire
Allen, Stephen J.
BMJ PAEDIATRICS OPEN, 2024, 8 (SUPPL_1)

← 1 2 3 4 5 →